All posts by: Michael Zand

About Michael Zand

U.S. Stem Cell, Inc.’s MARVEL Phase II/III Trial Receives Reactivation Status with the FDA – Yahoo Finance

Continue reading

2017-04-10 NEWS

U.S. Stem Cell, Inc.’s MARVEL Phase II/III Trial Receives Reactivation Status with the FDA
Yahoo Finance
SUNRISE, FL / ACCESSWIRE / April 10, 2017 / U.S. Stem Cell, Inc. (USCC) (USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal patients, has received reactivation …

and more »

Continue reading

2017-04-10 NEWS

Genetic Literacy Project

Questions abound on synthetic biology: Is it creating ‘new life’ or just part of biotechnology’s toolkit?
Genetic Literacy Project
My guess is that both the methods and the technology of synthetic biology — and here I’m thinking particularly of DNA synthesis — will continue to become more common, less remarked upon, and just part of the toolkit of biotechnology and bioengineering.

Continue reading

2017-04-10 NEWS

Civil Eats

Monsanto’s Driverless Car: Is CRISPR Gene Editing Driving Seed Consolidation?
Civil Eats
And it’s just one of many indications that CRISPR/Cas9 and other next-generation gene editing technologies will likely be at the forefront of the seed industry in the years ahead. Some even see gene editing, which is said to be simpler, less expensive

Continue reading

2017-04-10 NEWS

Bacterial Physiology Phage injection establishes CRISPR immunity
Nature.com
The CRISPR–Cas system protects bacteria from invaders by acquiring short DNA sequences from infecting viruses. These sequences (spacers) protect against subsequent infection by mediating the cleavage of invading DNA by Cas nuclease. The details of …